We are live on ! Find out more
CVKD icon

Cadrenal Therapeutics
CVKD

17 hedge funds and large institutions have $824K invested in Cadrenal Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 16 → 17 (+1)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.21% less ownership

Funds ownership: 3.69% → 3.48% (-0.21%)

33% less capital invested

Capital invested by funds: $1.22M → $824K (-$399K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$48.7K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$44K
3
Raymond James Financial
Raymond James Financial
Florida
+$28.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.27K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.02K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$121K
2
Osaic Holdings
Osaic Holdings
Arizona
-$14.9K
3
Morgan Stanley
Morgan Stanley
New York
-$10.4K
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.76K
5
PWA
Physician Wealth Advisors
Utah
-$917
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$586K +$44K +2,962 +6%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$153K +$9.27K +624 +5%
BlackRock
3
BlackRock
New York
$39.5K +$48.7K +3,282 New
Raymond James Financial
4
Raymond James Financial
Florida
$23.1K +$28.5K +1,917 New
Osaic Holdings
5
Osaic Holdings
Arizona
$6.03K -$14.9K -1,000 -67%
Morgan Stanley
6
Morgan Stanley
New York
$5.18K -$10.4K -700 -62%
UBS Group
7
UBS Group
Switzerland
$3.93K -$121K -8,119 -96%
Jones Financial Companies
8
Jones Financial Companies
Missouri
$1.8K – – –
TRCT
9
Tower Research Capital (TRC)
New York
$1.64K +$2.02K +136 New
Wells Fargo
10
Wells Fargo
California
$1.21K – – –
HI
11
Harbour Investments
Wisconsin
$1.21K +$1.49K +100 New
AIC
12
Archer Investment Corporation
Indiana
$422 – – –
IA
13
IFP Advisors
Florida
$362 – – –
FFA
14
Farther Finance Advisors
California
$301 – – –
CWA
15
Carolina Wealth Advisors
South Carolina
$241 – – –
Bank of America
16
Bank of America
North Carolina
$169 +$45 +3 +27%
CSC
17
Caldwell Sutter Capital
California
$60 – – –
JP Morgan Chase
18
JP Morgan Chase
New York
– -$1.76K -100 Closed
PWA
19
Physician Wealth Advisors
Utah
– -$917 -52 Closed
FFA
20
Frazier Financial Advisors
Ohio
– -$177 -10 Closed

CVKD Hedge Fund Activity: Q2 2025 in Review

17 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Cadrenal Therapeutics (CVKD) for Q2 2025, worth a combined $824K — down 33% from $1.22M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CVKD positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $48.7K. The largest seller was UBS Group, cutting an estimated $121K.

  • 17 institutional investors held Cadrenal Therapeutics (CVKD) as of Q2 2025, up from 16 in Q1 2025.
  • Funds reported $824K of Cadrenal Therapeutics stock for Q2 2025, down 33% quarter-over-quarter.
  • 4 funds opened new Cadrenal Therapeutics positions in Q2 2025 and 3 closed out, a net change of +1 holder.
  • The largest Cadrenal Therapeutics buyer in Q2 2025 was BlackRock, an estimated $48.7K added.
  • The largest Cadrenal Therapeutics seller in Q2 2025 was UBS Group, an estimated $121K sold.

Based on aggregated 13F filings for Q2 2025.